E-prescribing and medication management software with AI-driven data tools
DrFirst builds e-prescribing and medication-data software for providers, running on an AWS-centric stack (Aurora, EKS, DynamoDB, Bedrock) with Kubernetes, ArgoCD and GitLab CI/CD. Voice and AI components like Whisper, Deepgram and WebRTC, plus pain points around unstable bots and inaccurate AI responses, show conversational AI is in production but still maturing. Active work on direct payer and prior authorization integrations signals a push deeper into the payer side of prescribing.
DrFirst, Inc. is a privately held healthcare technology company founded in 2000 and headquartered in Arlington, Virginia. It focuses on medication management, covering e-prescribing, medication history, patient adherence and AI-based aggregation of clinical data. Its customers are healthcare providers and hospital information system environments, including MEDITECH settings. The company employs 201–500 people and hires in the United States across engineering, support, sales, data, marketing and product roles.
DrFirst runs on AWS (Aurora, EKS, DynamoDB, Bedrock, CloudWatch) with PostgreSQL, Python, FastAPI, Go, React, Next.js, Kafka and gRPC, deployed via Kubernetes, Helm, ArgoCD and GitLab CI/CD.
Current initiatives include stabilizing AI bots, migrating databases to AWS Aurora, e-prescribing platform development, direct payer integrations, prior authorization workflows and AI features in its BI product.
DrFirst is headquartered in Arlington, Virginia, United States, and is a privately held company with 201–500 employees, founded in 2000.
Other companies in the same industry, closest in size
DrFirst, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.